Attached files

file filename
10-K - ANNUAL REPORT - TENAX THERAPEUTICS, INC.oxbt_10k.htm
EX-32.2 - CERTIFICATION - TENAX THERAPEUTICS, INC.oxbt_ex322.htm
EX-31.1 - CERTIFICATION - TENAX THERAPEUTICS, INC.oxbt_ex311.htm
EX-31.2 - CERTIFICATION - TENAX THERAPEUTICS, INC.oxbt_ex312.htm
EX-32.1 - CERTIFICATION - TENAX THERAPEUTICS, INC.oxbt_ex321.htm
EX-10.27 - EMPLOYMENT AGREEMENT - TENAX THERAPEUTICS, INC.oxbt_ex1027.htm
EX-10.23 - AMENDED AND RESTATED EMPLOYMENT AGREEMENT - TENAX THERAPEUTICS, INC.oxbt_ex1023.htm
EX-10.35 - AMENDED AND RESTATED EMPLOYMENT AGREEMENT - TENAX THERAPEUTICS, INC.oxbt_ex1035.htm
EX-10.33 - RESIGNATION OF EMPLOYMENT AND CONSULTING AGREEMENT - TENAX THERAPEUTICS, INC.oxbt_ex1033.htm
EX-10.36 - FORM OF INDEMNIFICATION AGREEMENT - TENAX THERAPEUTICS, INC.oxbt_ex1036.htm

 
EXHIBIT 23.1
 
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
 
We hereby consent to the incorporation by reference in the Registration Statement of Oxygen Biotherapeutics, Inc. on Form S-8 (No. 333-167175) and related prospectuses as well as the Registration Statement of Oxygen Biotherapeutics, Inc. on Form S-3 (No. 333-165733) of our audit report dated July 14, 2011, with respect to the financial statements of Oxygen Biotherapeutics, Inc., which report appears in the Annual Report on Form 10-K of Oxygen Biotherapeutics, Inc. for the years ended April 30, 2011 and 2010.
 
 
CHERRY, BEKAERT & HOLLAND, L.L.P.
 
 
/s/ Cherry, Bekaert & Holland, L.L.P.
 
Raleigh, North Carolina
July 14, 2011